GLP-1 receptor agonists, by achieving greater weight loss than obtained with other medications, may represent a therapeutic opportunity for improving obesity in patients with PsO and HS, with resulting decrease in CVR and, in general, improvement in the medium to long term
Clinical studies have shown patients may lose 1215% of their body weight under proper medical supervision
We cover medications, pricing, provider quality, billing issues, and refund policy based on real patient data
Avoiding greasy and heavy foods is important as these can worsen nausea and gastrointestinal discomfort on GLP-1 medications (Mahase, 2023)
However, its often a result of the metabolic and endocrinologic changes that go along with weight loss
How Long Do You Use GLP-1 Receptor Agonists